Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
LAMISIL SOLUTION |
| Manufacturer |
|
Novartis Pharmaceuticals Corp |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Allylamine antifungal. |
| Generic Name |
|
Terbinafine HCl 1%. |
| Also |
• LAMISIL AT CREAM
• LAMISIL AT SOLUTION
|
| Indications |
|
Tinea versicolor. |
| Children |
|
<18 years: not recommended. |
| Adults |
|
≥18 years: apply twice daily for 1 week. Improvement may continue for 2–7 weeks after therapy completed. |
| Precautions |
|
Avoid eyes, nose, mouth, other mucous membranes, scalp, nails, and use of occlusive dressings. Do not use soln spray on face. Discontinue if irritation or sensitivity develops. Pregnancy (Cat.B). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Local irritation, burning, itching, dryness. Soln: also skin exfoliation, erythmatous rash. |
| How Supplied |
Soln—30mL (pump spray)
Crm—12g, 24g
AT Soln—30mL (pump spray or dropper) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
